Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126395471 | 12639547 | 1 | I | 20160801 | 20160810 | 20160810 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064162 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126395471 | 12639547 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 2 MG, QD | N | 21436 | 2 | MG | QD | ||||||
| 126395471 | 12639547 | 2 | SS | REXULTI | BREXPIPRAZOLE | 1 | Oral | 0.5 MG, QD | N | BRC00416 | 0 | .5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126395471 | 12639547 | 1 | Bipolar disorder |
| 126395471 | 12639547 | 2 | Bipolar disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126395471 | 12639547 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126395471 | 12639547 | Depression | |
| 126395471 | 12639547 | Prescribed underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126395471 | 12639547 | 2 | 20160725 | 20160727 | 0 |